
    
      This is a single-center, single arm, open label study in senior men. This study will
      investigate the effect and tolerance of oral ingestion of Euryco-10. Subjects meeting all
      inclusion and none of the exclusion criteria will be enrolled and provided with study dietary
      supplement. Subjects will be instructed to take 2 capsules per day for 35 days.
      Administration and any adverse events will be recorded in the subject diary. At each clinic
      visit (Day 0, Day 21 and Day 35) the Subject will complete the AMS Questionnaire.
    
  